This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Tobacco Use Disorder or Cigarette Smoking
and you are
between 18 and 45
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of the study is to compare two different dosage forms from which nicotine is released and absorbed into the bloodstream.

Provided treatments

  • Drug: Sublingual tablet 4 mg versus Nicorette Lozenge 4mg

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02906995. The sponsor of the trial is Friends Research Institute, Inc. and it is looking for 24 volunteers for the current phase.
Official trial title:
An Open-Label Pseudorandomized, Two Way Crossover Comparison of the Single-Dose Pharmacokinetics of Nicotine 4 mg Sublingual Tablets Versus Nicorette Lozenge 4 mg in Healthy Smokers Under Fasted Conditions